A three-dimensional pharmacophore hypothesis was developed for atypical antipsychotics in order to map common structural features of highly active compounds by using HipHop in CATALYST program. The pharmacophore hypotheses were generated using 12 compounds as training set and validated using 11 compounds as test set. The most predictive hypothesis (Hypo1) comprises five features viz. two hydrophobic regions, two hydrogen bond acceptor lipid and one aromatic ring. In the absence of information like crystallized structure of 5-HT2A receptor and binding mode of antipsychotics with 5-HT2A receptor, this hypothesis will serve as a potentially valuable tool in the design of novel atypical antipsychotics acting primarily at 5-HT2A and D2 receptors.
Introduction
Schizophrenia is a devastating mental disorder affecting 1% of the world's population with similar rates across different countries, cultural groups and sexes.
1,2 The disease is characterized by positive (hallucinations, delusions, disorganized speech, rambling monologues) and negative (alogia, avolition, anhedonia and flattened affect) symptoms.
3
Chlorpromazine was the first effective medicine discovered for schizophrenia followed by several agents, the so-called conventional antipsychotics. Conventional antipsychotics were found to cure only the positive symptoms, as they act as D 2 antagonists, and are characterized by undesirable effects, such as extra-pyramidal symptoms (EPS), hyperprolactinaemia, tardive dyskinesia (TD) and neuroleptic malignant syndrome. [4] [5] [6] [7] The discovery of clozapine (6) later led to the development of "atypical antipsychotics". Second Generation Antipsychotics (SGAs) or the atypical antipsychotics represent a new class of therapeutic agents, which posses better clinical efficacy in treating negative symptoms apart from positive symptoms as most of these molecules were found to act at various receptors. These drugs are also associated with side effects like EPS, TD and hyperprolactinemia, but to a lesser extent when compared to the conventional ones. Other important examples of such atypical antipsychotics are iloperidone (1), ziprasidone (2) , sertindole (3), risperidone (4), olanzapine (5) , quetiapine (7), amisulpride (8), melperone (9), zotepine (10), tiosperone (11) and aripiprazole (12) . But these compounds are also not completely devoid of side effects.
Side effects caused by SGAs are a result of their significant binding affinity to numerous receptors other than required for atypical antipsychotic activity. Side effects associated with SGAs include weight gain (Serotonergic 5-HT 2C 6 Not all the SGAs cause the above-mentioned adverse side effects. 4 Hence it can be concluded that there is still an unmet medical need for novel atypical antipsychotics that are devoid of these side effects. As part of the ongoing research in this direction in our laboratory 9 we thought it is worthwhile first to develop a suitable model based on the available drugs and then synthesize the new chemical entities accordingly.
In the absence of a 3D structure for a particular receptor protein of therapeutic interest, drug discovery and design efforts are often based on a model inferred from the different ligands that bind to it. Ligand-based drug design approach depends on a principle, which states that structurally similar compounds are more likely to exhibit similar properties. Atypical antipsychotics have affinity for both D 2 and 5-HT 2A receptors. Many currently available drugs in the market have affinities for these two receptors. 15 As very little information is known about the crystal structure of 5-HT 2A receptor, receptor based virtual screening cannot be performed efficiently. Thus, ligand based drug design appears the best choice for the design of novel atypical antipsychotics. It can aid the identification of the common 3D features present in diverse molecules that act at the same biological target. The aim of this work is to derive feature-based 3D model from a set of atypical antipsychotics using HipHop. In this paper, a pharmacophore model is developed based on the existing atypical antipsychotics. [10] [11] [12] [13] As part of ligand based screening, we developed a pharmacophore hypothesis model using HipHop model in CATALYST 4.11
14 from 12 diverse compounds as training set and validated using 11 compounds as test set. HipHop generates hypotheses consisting only of identification and overlay of common features (without the use of activity data). The preliminary data set for pharmacophore generation included 125 antagonists (either D 2 or 5-HT 2A ) retrieved from literature and respective inhibition constants (K i ). We selected the training set using chosen compounds with human binding data, defined stereochemistry and biological data (structures with K i > 300 nM were excluded from the training set). 12 compounds with structural diversity and high activity were finally chosen to develop the model.
The most critical aspect in the generation of the pharmacophore hypothesis using CATALYST 4.11 is selection of the training set. Some basic guidelines have been followed for the selection of training set e.g. a minimum of 10-12 diverse compounds have been selected to avoid any chance correlation; the compounds are selected to provide clear, concise information to avoid redundancy or bias in terms of both structural features and activity range and the most of the highly active compounds are included so that they provide information on the most critical features required for a reliable/rational pharmacophore model. The series of marketed and preclinical atypical antipsychotics and typical antipsychotics consisting of 23 compounds was chosen as training and test sets for the present study.
14-17 The training set ( Figure 1 ) consisting of 12 compounds was selected considering the above guidelines while 11 compounds were taken for test set ( Figure 2 ) for further validation of the model (Table 1) .
All molecular modeling studies were performed using CATALYST 4.11. All the structures were built and geometry optimized using CHARMm force field implemented in the program. The conformations were generated using the maximum limit of 255 conformations within a 20 kcal cutoff for the common feature pharmacophore generation using the HipHop module.
14,25,26
Considering the prospects of atypical antipsychotics as potential agents for the treatment of schizophrenia, we have generated a pharmacophore model of atypical antipsychotics acting at 5HT 2A and D 2 receptors. HipHop, 3D pharmacophore generation, is a common feature based alignment. Here quantitative activity of the compounds is not taken into consideration for hypothesis generation, rather hypotheses are produced by comparing a set of conformational models and a number of 3D configurations of chemical features of training set compounds.
27
CATALYST automatically generated conformational models for each compound. Conformation generating algorithms were adjusted to produce a diverse set of conformations, avoiding repetitious groups of conformations all representing local minima. The conformations generated were used to align common molecular features and generate pharmacophore hypotheses. HipHop used the generated conformations to align chemically important functional groups common to the compounds in the training set and generate a pharmacophore hypothesis from these aligned structures. The models showed a conformational diversity under the constraint of 20 kcal/mol energy threshold above the estimated global minimum based on the CHARMm force field. CATALYST provides two types of conformational analysis: fast and best quality. Best option was used, specifying 255 as the maximum number of conformers. 26, 28 The compounds associated with the conformational model were submitted to CATALYST hypothesis generation. Hypotheses approximating the pharmacophore were described as set of features distributed within 3D space. This process only considered surface accessible functions such as hydrogen-bond acceptor (HBA), hydrogen-bond acceptor lipid (HBAL), hydrogenbond donor (HBD), hydrophobic (HY), ring aromatic (RA), and positive ionizable (PI).
HipHop provides feature-based alignment of a group of compounds without considering activity. It matches the chemical features of a molecule, against drug candidate molecules. HipHop utilizes a collection of conformational models of compounds and a selection of chemical features, and produces a series of molecular alignments. HipHop also maps partial features of compounds in the alignment set. This provision gives the option to use partial mapping during the alignment. Partial mapping allows to identify larger, more diverse, more significant hypotheses and alignment models without the risk of missing compounds that do not map to all of the pharmacophore features. 27, 29, 30 In this paper, the generation of a pharmacophore model for atypical antipsychotics from training set of twelve compounds using HipHop method has been carried out. In the model generation methodology, the highest weight was assigned to the compound 1 (iloperidone, as it is the recent drug released in the market with less side effects compared to earlier drugs) in the training set, by assigning a value of 2 (which ensures that all of the chemical features in the compound will be considered in building hypothesis) and 0 (which forces mapping of all features of the compound) in the Principle and Maximum Omitting Features (Table 2 ), respectively. A value of 1 for the principle column ensures that at least one mapping for each of generated hypotheses will be found, and a value of 1 for the maximum omitting features column ensures that all but one feature must map for all other compounds in the training set. All other parameters were kept at the default settings. In the absence of the activity data, all the features of the training set of compounds were taken as reference molecule data in such a way that it would satisfy features of all the compounds.
29,30
Results and Discussion
From HipHop method, 10 hypotheses (Hypo) were generated based on test set of compounds and scores ranged from 130.613 to 117.05 (Table 3 ). This small range of ranking score and same features in all hypotheses suggests that the same five features are spatially arranged almost similarly in all hypotheses. Also the compounds of the training set were mapped on to each of the hypotheses and checked for fit values. Hypothesis model has five features, and hence, the maximum fit value of any ligand alignment with this model would be at most 5.0. As all the hypotheses had the same features, selection of best hypothesis was done based on the rank and fit value of test and training sets. Fit values and relative energies (energy in comparision to iloperidone) of compounds of training set are tabulated in (Table 4) . Among the hypotheses, Hypothesis 1 (Hypo1) of rank 130.613 is the best hypothesis.
The selected pharmacophore model Hypo1 totally contained five chemical features namely two hydrophobic (HY-1 & HY-2), two hydrogen bond acceptors-lipid (HBAl-1 & HBAl-2) and one aromatic ring (RA) (Figure 3) . The distances between these features in are tabulated (Table 5) .
Alignment of Hypo1 with test set of compounds was performed and found to give fit scores ranging from 3.06 to 4.88 (Table 6 ). Compounds 15, 16, 17 and 19 showed mapping to all the features of the model generated by HipHop. Among the test set compounds, compound 17 has 4H-chromen-4-one ring, flouro and ethoxy groups and exhibited maximum fit value of 4.88. Compounds 13, 18, 20, 21, 22 and 23 didn't show mapping to the hydrogen bond acceptor feature while compound 14 didn't show mapping to hydrophobic feature (* in Table 6 ). According to Meltzer for atypical antipsychotic activity a compound should exhibit 5- 
a Principle = 1 means that this compound must map onto the hypotheses generated by the search procedure. Partial mapping is allowed. Principle = 2 means that this is a reference compound. The chemical feature space of the conformers of such a compound is used to define the initial set of potential hypotheses. HT 2A /D 2 ratio greater than 1.12. 20 As reported in literature, 22 17 has higher affinity for 5HT 2A receptors than D 2 receptors which an atypical antipsychotic should normally exhibit. Figure 4 (a) represents compound 17 with a fit value of 4.88, in which the HBAL-1 maps the oxygen of isoxazole ring of benzisoxazole, HBAl-2 maps the carboxyl oxygen of 4H-chromen-4-one, the HY-1 feature maps theflouro group of benzisoxazyl ring attached to piperidine group, the HY-2 feature maps the phenyl group of 4H-chromen-4-one and aromatic ring (RA) feature maps the phenyl ring of 4H-chromen-4-one of compound 17.
To further strengthen the proposed pharmacophore model as part of the ongoing research, we synthesized three series of molecules viz., 1,8-naphthyridine, quinoxaline and substituted piperazine derivatives and tested for mapping to model Hypo1 ( Figure 5 ). All the above three series of compounds are synthesized, evaluated for their pharmacological activity along with receptor binding profiles and published.
9a-d Summarized are the result whose fit scores range from 3.56 to 4.84 (Table 7) . Compound NC1 and NC6 exhibited good response to every features of the proposed HipHop model. Out of these two compounds NC1 having fit value of 4.84 was found to be the most active compound in the pharmacological screening (5-HT 2a /D 2 ratio of 1.14).
9a
Compound P3 which doesn't have aromatic ring was found to be inactive in pharmacological screening (5-HT 2a /D 2 ratio of 0.44) 9c and compound P4, QCMH1 and QCMH2 9d didn't show mapping to hydrophobic feature (* in Table 7 ). Compounds P4, QCC3, QCC4, QCMO5 and QCMO6 didn't show mapping to the hydrogen bond acceptor feature. As we summarized earlier fit values greater than 4.0 for compounds have greater affinity for 5HT 2A receptors than D 2 receptors in the test set namely NC1 indicate the validity of the model.
Conclusions
In rational drug design process, it is common that the biological-activity data of a set of compounds acting upon a particular protein is known, while information on the threedimensional structure of the protein active site is absent. A three-dimensional pharmacophore hypothesis that is consistent with existing compounds should be useful and predictive in evaluating new compounds and directing further synthesis. We have generated pharmacophore hypotheses for atypical antipsychotics using the HipHop model of CATALYST 4.11. The present work shows how a set of active compounds can uncover the molecular characteristics or features essential for activity. The results of the pharmacophore model revealed that 2 hydrogen bond acceptors (lipid), 2 hydrophobic features and an aromatic ring are significant for effective atypical antipsychotics acting primarily at 5-HT 2A and D 2 receptors. The model generated hypotheses (1-10) with rank scores ranging from 130-117 and results with training set led to the selection of Hypo1 as the best hypothesis. The mapping of compounds of test set to Hypo1 yielded considerable fit values with a maximum fit value of 4.88 for 17. Also compounds 15, 16 and 19 showed mapping to all the features of the developed pharmacophore model with fit values greater than 4.0. This result is in congruence with the reported literature, which shows the higher affinity of these compounds towards 5-HT 2A than D 2 receptors, 22 which an atypical antipsychotic should possess in order to show less extra-pyramidal side effects. The compounds 13, 18, 20, 21, 22 and 23 didn't show mapping to hydrogen bond acceptor (lipid) feature while compound 14 didn't show mapping to hydrophobic group feature. This result is in congruence with 
